163 related articles for article (PubMed ID: 26889755)
1. Comparison of outcome of patients with CLL who are referred or nonreferred to a specialized CLL clinic: a Canadian population-based study.
Beiggi S; Banerji V; Deneka A; Griffith J; Gibson SB; Johnston JB
Cancer Med; 2016 Jun; 5(6):971-9. PubMed ID: 26889755
[TBL] [Abstract][Full Text] [Related]
2. Patterns and predictors of referral to the specialized chronic lymphocytic leukemia clinic in Manitoba, Canada.
Righolt CH; Zhang G; Gibson SB; Johnston JB; Banerji V; Mahmud SM
Cancer Epidemiol; 2022 Dec; 81():102279. PubMed ID: 36279643
[TBL] [Abstract][Full Text] [Related]
3. Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
Shanafelt TD; Kay NE; Rabe KG; Inwards DJ; Zent CS; Leis JF; Schwager SM; Thompson CA; Bowen DA; Witzig TE; Slager SL; Call TG
Cancer; 2012 Apr; 118(7):1827-37. PubMed ID: 22009554
[TBL] [Abstract][Full Text] [Related]
4. Chronic lymphocytic leukemia patients with HLA-B27 referred for allogeneic hematopoietic stem cell transplantation do not have worse outcomes: Results of a population-based case series analysis in British Columbia, Canada.
Huang SJ; Chan J; Bruyère H; Allan LL; Gerrie AS; Toze CL
Leuk Res; 2019 Sep; 84():106193. PubMed ID: 31325731
[TBL] [Abstract][Full Text] [Related]
5. Differentiating Chronic Lymphocytic Leukemia from Small Lymphocytic Lymphoma: A Manitoba Cancer Registry Perspective.
Deneka A
J Registry Manag; 2016; 43(2):90-1. PubMed ID: 27556844
[TBL] [Abstract][Full Text] [Related]
6. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
[TBL] [Abstract][Full Text] [Related]
7. Challenges in assessing the real incidence of chronic lymphocytic leukemia: 16 years of epidemiological data from the province of Girona, Spain.
Solans M; Osca-Gelis G; Comas R; Roncero JM; Gallardo D; Marcos-Gragera R; Saez M
Cancer Causes Control; 2018 Mar; 29(3):379-382. PubMed ID: 29383469
[TBL] [Abstract][Full Text] [Related]
8. High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: a population-based Canadian cohort.
Seftel MD; Demers AA; Banerji V; Gibson SB; Morales C; Musto G; Pitz MW; Johnston JB
Leuk Res; 2009 Nov; 33(11):1463-8. PubMed ID: 19581000
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology.
Dores GM; Anderson WF; Curtis RE; Landgren O; Ostroumova E; Bluhm EC; Rabkin CS; Devesa SS; Linet MS
Br J Haematol; 2007 Dec; 139(5):809-19. PubMed ID: 17941952
[TBL] [Abstract][Full Text] [Related]
11. IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia.
Ishdorj G; Streu E; Lambert P; Dhaliwal HS; Mahmud SM; Gibson SB; Banerji V; Marshall AJ; Johnston JB
Blood Adv; 2019 Jul; 3(14):2188-2198. PubMed ID: 31324639
[TBL] [Abstract][Full Text] [Related]
12. Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death.
Kyasa MJ; Hazlett L; Parrish RS; Schichman SA; Zent CS
Leuk Lymphoma; 2004 Mar; 45(3):507-13. PubMed ID: 15160912
[TBL] [Abstract][Full Text] [Related]
13. Trends of incidence, mortality and survival for chronic lymphocytic leukaemia / small lymphocytic lymphoma in Switzerland between 1997 and 2016: a population-based study.
Andres M; Feller A; Arndt V; The Nicer Working Group
Swiss Med Wkly; 2021 Mar; 151():w20463. PubMed ID: 33793959
[TBL] [Abstract][Full Text] [Related]
14. Survival, causes of death, and the prognostic role of comorbidities in chronic lymphocytic leukemia in the pre-ibrutinib era: A population-based study.
Steingrímsson V; Lund SH; Dickman PW; Weibull CE; Björkholm M; Landgren O; Kristinsson SY
Eur J Haematol; 2022 Feb; 108(2):145-153. PubMed ID: 34714556
[TBL] [Abstract][Full Text] [Related]
15. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
16. Impact of active surveillance, chlorambucil, and other therapy on health-related quality of life in patients with CLL/SLL in the Netherlands.
van den Broek EC; Oerlemans S; Nijziel MR; Posthuma EF; Coebergh JW; van de Poll-Franse LV
Ann Hematol; 2015 Jan; 94(1):45-56. PubMed ID: 25038918
[TBL] [Abstract][Full Text] [Related]
17. The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia.
Martínez-Trillos A; Pinyol M; Delgado J; Aymerich M; Rozman M; Baumann T; González-Díaz M; Hernández JM; Alcoceba M; Muntañola A; Terol MJ; Navarro B; Giné E; Jares P; Beà S; Navarro A; Colomer D; Nadeu F; Colado E; Payer AR; García-Cerecedo T; Puente XS; López-Otin C; Campo E; López-Guillermo A; Villamor N
Leuk Lymphoma; 2018 Oct; 59(10):2318-2326. PubMed ID: 29115891
[TBL] [Abstract][Full Text] [Related]
18. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes.
Parikh SA; Leis JF; Chaffee KG; Call TG; Hanson CA; Ding W; Chanan-Khan AA; Bowen D; Conte M; Schwager S; Slager SL; Van Dyke DL; Jelinek DF; Kay NE; Shanafelt TD
Cancer; 2015 Sep; 121(17):2883-91. PubMed ID: 25931291
[TBL] [Abstract][Full Text] [Related]
19. Evaluating population-level outcomes in Chronic Lymphocytic leukemia in the era of novel therapies using the SEER registry.
Muthiah C; Narra R; Atallah E; Juan W; Szabo A; Guru Murthy GS
Leuk Res; 2024 May; 140():107496. PubMed ID: 38547577
[TBL] [Abstract][Full Text] [Related]
20. [Chronic lymphocytic leukemia in Iceland from 2003 to 2013: Incidence, presentation and diagnosis].
Olafsson GB; Steingrimsdottir H; Vidarsson B; Halldorsdottir AM
Laeknabladid; 2016 Apr; 102(4):171-7. PubMed ID: 27197124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
